Combinatorial Epigenetic and Immunotherapy in Breast Cancer Management: A Literature Review.
Ontology highlight
ABSTRACT: Breast cancer is one of the leading causes of death among cancer patients worldwide. To date, there are several drugs that have been developed for breast cancer therapy. In the 21st century, immunotherapy is considered a pioneering method for improving the management of malignancies; however, breast cancer is an exception. According to the immunoediting model, many immunosuppressive cells contribute to immunological quiescence. Therefore, there is an urgent need to enhance the therapeutic efficacy of breast cancer treatments. In the last few years, numerous combinatorial therapies involving immune checkpoint blockade have been demonstrated that effectively improve clinical outcomes in breast cancer and combining these with methods of targeting epigenetic regulators is also an innovative st
SUBMITTER: Lee YT
PROVIDER: S-EPMC8594694 | biostudies-literature | 2020 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA